MEHLMAN CONSULTING, INC.

Lobbying for VIZIENT INC · Healthcare services company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

340b drug pricing program. Issues related to pharmacy benefit manager reform. Health care workforce. Health care supply chain. Health care drug shortages.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.